Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Biopharma Cred. Share News (BPCR)
BPCR Share
Price
BPCR Share
News
BPCR Share
Chat
BPCR Share
Trades121
BPCR
Live RNS
BPCR Share
Charts
BPCR Level 2
Console
BPCR Live
Share Price
BPCR Broker
Ratings
BPCR Directors
Deals
BPCR Financial
Diary
BPCR
Fundamentals
BPCR Short
Positions
BPCR
Media
BPCR Company
Research
BPCR Company
Timeline
Biopharma Cred. Information
Share Price Information for Biopharma Cred. (BPCR)
Share Price is delayed by 15 minutes
Get Live Data
0.946
0.002 (0.21%)
Bid:
0.944
Ask:
0.946
Spread:
0.002 (0.212%)
Market Cap:
$1.06b
Last checked at -
Last checked at 
Intraday Biopharma Cred. Share Chart
Biopharma Cred. News
14 Feb 2022
TRADING UPDATES: BioPharma backs Collegium; Eurasia creates Kola
(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:
10 Jan 2022
TRADING UPDATES: Harvest Minerals sales jump; Quartix earnings to rise
TRADING UPDATES: Harvest Minerals sales jump; Quartix earnings to rise
15 Dec 2021
IN BRIEF: BioPharma Credit invests USD112.5 million into two firms
IN BRIEF: BioPharma Credit invests USD112.5 million into two firms
8 Oct 2021
TRADING UPDATES: Harbour prices notes; Lekoil nears audit completion
TRADING UPDATES: Harbour prices notes; Lekoil nears audit completion
5 Oct 2021
IN BRIEF: BioPharma Credit moves listing to London Premium Segment
IN BRIEF: BioPharma Credit moves listing to London Premium Segment
23 Sep 2021
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
15 Sep 2021
TRADING UPDATES: Strong interim results from Epwin, Bridgepoint
TRADING UPDATES: Strong interim results from Epwin, Bridgepoint
13 Sep 2021
IN BRIEF: BioPharma Credit amends credit facility with JPMorgan Chase
IN BRIEF: BioPharma Credit amends credit facility with JPMorgan Chase
Follow the stocks
